BLUE | Jotup

bluebird bio, Inc. (BLUE) Class Action Notice: Robbins LLP Reminds Stockholders of Lead Plaintiff Deadline in Class Action Against bluebird bio, Inc.

Retrieved on:

Tuesday, April 9, 2024

Bluebird is a biotechnology company that researches, develops, and commercializes gene therapies for severe genetic diseases.

Key Points:

Bluebird is a biotechnology company that researches, develops, and commercializes gene therapies for severe genetic diseases.
For more information, submit a form , email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.
A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation.
If you choose to take no action, you can remain an absent class member.

Undavia Group Files Definitive Proxy Statement and Issues Letter to GrafTech Shareholders

Retrieved on:

Wednesday, April 3, 2024

Failure, Environment, CFO, ALL, Accounting, IPO, Human, Morale, Social Democrats (Slovenia), GrafTech, BLUE, Interim, Government, EAF, Annual general meeting, Management

BOCA RATON, Fla., April 03, 2024 (GLOBE NEWSWIRE) -- Nilesh Undavia issued the following statement on April 3, 2024:

Key Points:

Shareholders and bondholders have suffered wanton value destruction: shares are down 90% since the IPO and the Company’s bonds trade at 64 cents on the dollar.
Mr. Undavia has invested significant capital in buying GrafTech shares, representing approximately 5.9% of the Company’s outstanding shares.
The Undavia Group (Nilesh Undavia and certain family trusts) have filed with the SEC a definitive proxy statement on Schedule 14A (the “Proxy Statement”), containing a form of BLUE proxy card, with respect to its solicitation of proxies for the Annual Meeting.
Copies of the documents filed by the Undavia Group are available free of charge by accessing the website at https://www.icomproxy.com/EAF .

bluebird bio, Inc. Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm for More Information – BLUE

Retrieved on:

Wednesday, April 3, 2024

Sickle cell disease, AML, Blue, Patient, History, News, Complaint, BLUE, Fraud, NEXT, FDA, Bluebird bio, Food, Security (finance)

NEW YORK, April 03, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of bluebird bio, Inc. (NASDAQ: BLUE).

Key Points:

NEW YORK, April 03, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of bluebird bio, Inc. (NASDAQ: BLUE).
Shareholders who purchased shares of BLUE during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices.
The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship.

Investor Notice: Robbins LLP Informs Investors of Class Action Filed Against bluebird bio, Inc. (BLUE)

Retrieved on:

Saturday, March 30, 2024

SAN DIEGO, March 30, 2024 (GLOBE NEWSWIRE) -- Robbins LLP informs investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired bluebird bio, Inc. (NASDAQ: BLUE) common stock between April 24, 2023 and December 8, 2023.

Key Points:

SAN DIEGO, March 30, 2024 (GLOBE NEWSWIRE) -- Robbins LLP informs investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired bluebird bio, Inc. (NASDAQ: BLUE) common stock between April 24, 2023 and December 8, 2023.
Bluebird is a biotechnology company that researches, develops, and commercializes gene therapies for severe genetic diseases.
For more information, submit a form , email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.
A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors It Has Filed a Complaint to Recover Losses Suffered by Purchasers of bluebird bio, Inc. Common Stock and Sets a Lead Plaintiff Deadline of May 28, 2024

Retrieved on:

Thursday, March 28, 2024

Sickle cell disease, AML, Telephone, Blue, District court, Patient, History, News, LLP, E pluribus unum, BLUE, FDA, Court, Bluebird bio, Food, Person

You are hereby notified that the class action lawsuit Garry Gill v. bluebird bio, Inc., et al.

Key Points:

You are hereby notified that the class action lawsuit Garry Gill v. bluebird bio, Inc., et al.
1:24-cv-10803) has been commenced in the United States District Court for the District of Massachusetts.
Following this news, Blue’s stock price fell by $1.95 per share, or approximately 40% to close at $2.86 per share.
If you suffered a loss in BLUE common stock, you have until May 28, 2024 to request that the Court appoint you as lead plaintiff.

New Report Reveals Demand for Youth Banking is High Among Families with Generation Z and Alpha Children

Retrieved on:

Thursday, March 28, 2024

Growth, Parent, Generation Z, Q2, Alpha, Bank, BLUE, Future

In addition, the report highlights the transformative impact youth banking solutions can have on the growth of financial institutions.

Key Points:

In addition, the report highlights the transformative impact youth banking solutions can have on the growth of financial institutions.
In recent years, banks and credit unions have faced a multitude of challenges related to digital disruption and new financial technology entrants.
To combat these challenges, financial institutions have focused on increasing customer loyalty and deposit growth.
According to the report, a significant majority of parents (57.2%) express a preference for their existing banking provider when considering a youth banking solution.

HarbourView Equity Partners Continues Expansion Into Film/TV with Investment in Mucho Mas Media

Retrieved on:

Monday, April 8, 2024

HarbourView Equity Partners (HarbourView), an industry-leading alternative asset management company focused on investment opportunities in the sports, media and entertainment space, announced today that they have invested in Mucho Mas Media – an inclusive LatinX multimedia platform cultivating talent and producing content for global audiences.

Key Points:

HarbourView Equity Partners (HarbourView), an industry-leading alternative asset management company focused on investment opportunities in the sports, media and entertainment space, announced today that they have invested in Mucho Mas Media – an inclusive LatinX multimedia platform cultivating talent and producing content for global audiences.
Through this investment, HarbourView will work closely with Mucho Mas’ management to drive ROI, leveraging HarbourView’s proprietary data driven insights into global audiences to deliver value to Mucho Mas and the HarbourView stakeholders.
Alongside Mucho Mas, HarbourView will executive produce the films in the Mucho Mas content slate including the upcoming feature THE LONG GAME, an adaptation of Humberto G. Garcia’s inspirational golf novel Mustang Miracle.
Mucho Mas Media was represented by Darrel Barros and Kimberly Mann at Shulman Rogers LLP, as well as Teresa Walsh and Tarek Sadi at Access Media Advisory.

Unisys Advancing AI Strategy, Names Brett Barton as Global AI Practice Leader

Retrieved on:

Monday, April 8, 2024

CIO, KPMG, Barton, The Sleepover Club, UIS, Boy, Artificial intelligence, Columbia University, AI, Slalom, Psychology, BLUE, Truman State University, Machine learning, Total, Management

BLUE BELL, Pa., April 8, 2024 /PRNewswire/ -- Unisys (NYSE: UIS) announced Brett Barton as the company's vice president and global AI practice leader.

Key Points:

BLUE BELL, Pa., April 8, 2024 /PRNewswire/ -- Unisys (NYSE: UIS) announced Brett Barton as the company's vice president and global AI practice leader.
"Our dedicated AI practice underscores our commitment to serve clients with cutting-edge AI solutions," said Unisys CEO Peter Altabef.
"Brett has a track record of propelling organizations forward through innovative initiatives, and we are excited to welcome him to Unisys."
Prior to joining Unisys, Barton built an advisory practice focused on AI and machine learning at Slalom, a global business and technology consulting company.

Rego Payment Architectures, Inc. Secures Extension of $20 Million Line of Credit

Retrieved on:

Tuesday, March 19, 2024

Fintech, COPPA, Privacy, Calendar, Congress, GDPR, Pressure, LOC, Parent, BLUE

BLUE BELL, Pa., March 19, 2024 (GLOBE NEWSWIRE) -- Rego Payment Architectures, Inc. (“REGO”) (OTCQB: RPMT), today announced it has secured an amendment to its $20 million line of credit (“LOC”) from one of its major investors, Mr. James Davison.

Key Points:

BLUE BELL, Pa., March 19, 2024 (GLOBE NEWSWIRE) -- Rego Payment Architectures, Inc. (“REGO”) (OTCQB: RPMT), today announced it has secured an amendment to its $20 million line of credit (“LOC”) from one of its major investors, Mr. James Davison.
This amendment extends the LOC until March 13, 2025.
Peter S. Pelullo, Chief Executive Officer at REGO, said, “This extension positions and solidifies the company’s ability to execute our strategic planning activities for 2024.
Banks and credit unions are now looking to FinTech providers like REGO, who can deliver a unique, one-of-a-kind offering that is COPPA & GDPR compliant, for their family wallet solutions.

Trian Sends Letter to Fellow Disney Shareholders Outlining the Need for Change

Retrieved on:

Monday, March 18, 2024

Letter, Growth, CFO, Sysco, Television, Heinz, Council, History, BLUE, Foreign policy, Procter & Gamble, Annual general meeting, Fear, Magic, Management

NEW YORK, March 18, 2024 (GLOBE NEWSWIRE) -- The Trian Group,1 which beneficially owns $3.5 billion of common stock in The Walt Disney Company (NYSE: DIS), today released a letter to its fellow Disney shareholders.

Key Points:

NEW YORK, March 18, 2024 (GLOBE NEWSWIRE) -- The Trian Group,1 which beneficially owns $3.5 billion of common stock in The Walt Disney Company (NYSE: DIS), today released a letter to its fellow Disney shareholders.
Dear Fellow Walt Disney Company Shareholder:
Disney’s 2024 Annual Meeting will be held on April 3, and it is time for you to vote to help Restore the Magic at Disney.
With its iconic franchises, global presence and scale, unparalleled customer loyalty and enviable commercial flywheel, Disney and its shareholders should prosper.
We have nominated two such candidates: Nelson Peltz and Jay Rasulo, each of whom have invested their own money in Disney stock and are dedicated to helping Disney.